Skip to content

Ammonium Chloride

Published: July 26, 2026Updated: August 25, 2026

Ammonium chloride is a systemic acidifying agent used primarily to correct metabolic alkalosis and to acidify the urine when medically indicated. It also has expectorant properties, helping to loosen and thin respiratory secretions. This medication is typically administered in clinical settings under medical supervision.

Quick summary

Ammonium chloride is an acidifying medication used to treat metabolic alkalosis and as an expectorant for respiratory conditions.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ATC
b05
RxNorm
unknown
Generic
Ammonium Chloride
Class
atc-b05
Brands
—
Availability
otc
Pregnancy
C
Lactation
caution
Half-life (h)
2
Onset (min)
15
Duration (h)
4
Routes
oral
Forms
syrup, tablet, powder
Regions
United States, United Kingdom, Canada, Australia
Monitoring
blood electrolytes, acid-base balance, urinary pH

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose that may cause serious toxicity in adults
Chronic overdose: Prolonged use leading to metabolic acidosis and electrolyte imbalances
Immediate actions
Gastric lavage within 1-2 hours of ingestion, activated charcoal, supportive care, monitor electrolytes and acid-base balance
Antidote
No specific antidote - supportive care only(Supportive treatment is the mainstay of management)
Poison Control: 1-800-222-1222

Special Populations

12 groups
✗

pregnancy

first trimester
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks

Monitor

regular fetal monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

pregnancy

second trimester
caution
FDA Category
C
Dose Adjustment

use only if clearly needed

Key Recommendations

use only when benefits outweigh potential risks

Monitor

fetal monitoring as needed

Use with caution and monitor for adverse effects.

⚠

pregnancy

third trimester
caution
FDA Category
C
Dose Adjustment

use only if clearly needed

Key Recommendations

avoid close to delivery due to potential effects on fetus

Monitor

fetal monitoring

Use with caution and monitor for adverse effects.

⚠

lactation

breastfeeding
caution
FDA Category
C
Dose Adjustment

avoid or discontinue breastfeeding

Key Recommendations

ammonia can pass into breast milk; consider alternative therapy

Monitor

monitor infant for symptoms

Use with caution and monitor for adverse effects.

✗

pediatric_age

infants
contraindicated
FDA Category
C
Dose Adjustment

do not use

Key Recommendations

not recommended for infants due to immature renal function and risk of metabolic disturbances

Monitor

not applicable

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

pediatric_age

children 2 12
caution
FDA Category
C
Dose Adjustment

reduced dose required

Key Recommendations

use with caution; monitor for metabolic changes

Monitor

regular monitoring of acid-base balance

Use with caution and monitor for adverse effects.

⚠

geriatric

elderly
caution
FDA Category
C
Dose Adjustment

dose reduction recommended

Key Recommendations

use with caution due to reduced renal function and electrolyte imbalance risk

Monitor

monitor renal function and electrolytes regularly

Use with caution and monitor for adverse effects.

⚠

renal_impairment

mild
caution
FDA Category
C
Dose Adjustment

reduce dose

Key Recommendations

use with caution; monitor renal function

Monitor

monitor renal function and electrolytes

Use with caution and monitor for adverse effects.

✗

renal_impairment

moderate
unsafe
FDA Category
C
Dose Adjustment

avoid or significantly reduce

Key Recommendations

not recommended due to reduced excretion

Monitor

frequent monitoring required if used

Use of this medication in this population requires careful consideration of risks and benefits.

✗

renal_impairment

severe
contraindicated
FDA Category
C
Dose Adjustment

do not use

Key Recommendations

contraindicated in severe renal impairment

Monitor

not applicable

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

hepatic_impairment

mild to moderate
caution
FDA Category
C
Dose Adjustment

use with caution

Key Recommendations

monitor liver function; ammonia metabolism may be impaired

Monitor

monitor ammonia levels and liver function

Use with caution and monitor for adverse effects.

✗

hepatic_impairment

severe
unsafe
FDA Category
C
Dose Adjustment

avoid

Key Recommendations

contraindicated in severe hepatic impairment due to ammonia metabolism

Monitor

not applicable

Use of this medication in this population requires careful consideration of risks and benefits.

Statistics and clinical data

prescribingFDA
2023

Commonly prescribed since

Value:1950s

General prescribing information for expectorant formulations

drug_classWHO
2023

Drug class

Value:Expectorant/Diuretic

Pharmacological classification

usageMedical guidelines
2023

Common uses

Value:Expectorant in cough medicines, urinary acidifying agent

Primary therapeutic applications

Treatment of metabolic alkalosis (a condition with excessively alkaline blood), urinary acidification when needed, and as an expectorant in cough preparations to help loosen and expel respiratory mucus.

Ammonium chloride dissociates into ammonium and chloride ions in the body. The ammonium is converted to urea in the liver, releasing hydrogen ions that help lower blood pH, thereby correcting alkalosis. As an expectorant, it stimulates respiratory secretions to help clear mucus.

Must be used with caution in patients with kidney or liver impairment, as these organs are involved in metabolizing and excreting the drug. Common side effects include gastrointestinal discomfort and potential for inducing metabolic acidosis if overused. Typically administered intravenously in clinical settings.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy